FBM 5712
Alternative Names: FBM-5712Latest Information Update: 23 Jun 2021
At a glance
- Originator Thirona Bio
- Developer MannKind Corporation; Thirona Bio
- Class Antifibrotics; Small molecules
- Mechanism of Action Transforming growth factor beta receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Fibrosis; Idiopathic pulmonary fibrosis